Technology | Computed Tomography (CT) | December 11, 2017

Philips Debuts IQon Elite Spectral CT Scanner at RSNA 2017

New configuration designed to enhance imaging for emergency/trauma care and oncology

Philips Debuts IQon Elite Spectral CT Scanner at RSNA 2017
 PhilipsIQonEliteSpectralCTbowelischemia

December 11, 2017 — At the 2017 Radiological Society of North America (RSNA) Annual Meeting, Philips unveiled the IQon Elite Spectral CT, designed to provide clinicians with increased diagnostic certainty in every scan. The system, a new configuration of the company's first spectral detector-based computed tomography (CT) scanner, debuts a suite of features that will enhance the clinical benefits of the IQon platform to improve diagnostic confidence while enhancing the patient experience, and supporting the needs of emergency/trauma and oncology care.    

This new configuration provides a number of enhanced features and benefits, including:

  • Enhanced diagnostic certainty - The IQon Elite’s faster reconstruction speeds and better visualization of bone marrow pathology enhance diagnostic confidence within emergency and trauma departments, providing the opportunity to reduce the need for subsequent scans. Its ability to estimate electron density provides enhanced tissue characterization, enabling a new level of diagnostic certainty for oncology clinicians and their patients.
  • Increased patient volume - IQon Elite has been shown to double patient throughput to 200 patients per day (based on a 16-hour clinical shift). This is an important benchmark for healthcare facilities experiencing a high volume of patients, especially in the emergency department where CT can be a commonly used imaging modality.
  • Enhanced clinical breadth – Its new radiation therapy planning couch and bariatric table top allow larger patients to be scanned with increased positioning controls.

The IQon Elite Spectral CT scanner will be available globally during the first quarter of 2018.

For more information: www.usa.philips.com/healthcare

Related Content

Accuray Incorporated announced the company has received CE Mark certification for its ClearRT helical fan-beam kVCT imaging capability.
News | Radiation Therapy | June 11, 2021
June 11, 2021 — Accuray Incorporated announced the company has received CE Mark certification for its...
News | PET-CT | June 10, 2021
June 10, 2021 — Bringing the power of...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
Prof. Jayant Vaidya, lead author of the study, University College London surgery and interventional science, performs a TARGI-IORT procedure. A small ball-shaped device placed inside the breast, directly where the cancer had been. The single-dose treatment lasts for around 20-30 minutes and replaces the need for extra hospital visits in eight out of ten cases.

Prof. Jayant Vaidya, lead author of the study, University College London surgery and interventional science, performs a TARGI-IORT procedure. A small ball-shaped device placed inside the breast, directly where the cancer had been. The single-dose treatment lasts for around 20-30 minutes and replaces the need for extra hospital visits in eight out of ten cases.

News | Radiation Oncology | June 02, 2021
June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional rad
An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

Feature | Computed Tomography (CT) | May 27, 2021 | By Dave Fornell, Editor
May 27, 2021 — Philips Healthcare released a workhorse...
The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation's capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. Image courtesy of Michael Story, Ph.D.

The experimental drug avasopasem manganese protects healthy tissue while enhancing radiation's capacity to kill cancerous tumor cells by converting superoxide to hydrogen peroxide. Image courtesy of Michael Story, Ph.D.

News | Radiation Therapy | May 21, 2021
May 21, 2021 — An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused